 |
 |
At 12:56 PM 21-02-97 -0500, you wrote: >On Thu, 20 Feb 1997 22:31:14 -0500 Ron Reiner <[log in to unmask]> >writes: >>Complimentary IBM DB2 Fast Start Conference! >>SIBIA Neurosciences Commences Phase I >>Clinical Trials in Parkinson's Disease With Its >>Proprietary Compound Targeting Nicotinic >>Acetylcholine Receptors >> >>Source: PR Newswire >> >>LA JOLLA, Calif., Feb. 18 /PRNewswire/ via Individual Inc. -- SIBIA >>Neurosciences, Inc. (Nasdaq NNM: SIBI) today announced that it has >>commenced under a U.S. IND a Phase I clinical trial in Parkinson's >>disease with SIB-1508Y, the Company's proprietary neuronal nicotinic >>acetylcholine receptor agonist. >> >>The trial will evaluate the safety and pharmacokinetics of SIB-1508Y.... > > Is there anyone on our wonderful list who can help me to understand >the relationship between SIB-1508Y, NADH, and mitochondrial Complex 1? > > The neurochemistry is becoming a neurochem-mystery!! > >Ivan S. > DITTO!>